Mirum Pharmaceuticals, Inc. (MIRM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$84.33
Day's range
$89.17

Mirum Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 05/15/2026 7.68 M $709.45 M   13.02% 15.30%
JANUS HENDERSON GROUP PLC 05/18/2026 6.95 M $641.76 M   14.52% 13.84%
BLACKROCK, INC. 05/13/2026 3.85 M $355.34 M   5.52% 7.66%
05/15/2026 2.41 M $223.08 M   100.00% 4.81%
FMR LLC 05/15/2026 1.97 M $181.56 M   204.02% 3.92%
STATE STREET CORP 05/15/2026 1.94 M $179.61 M   -9.31% 3.87%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.72 M $158.66 M   20.91% 3.42%
BVF INC/IL 05/15/2026 1.58 M $146.40 M   5.98% 3.16%
05/08/2026 1.43 M $132.30 M   100.00% 2.85%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 1.41 M $130.11 M   -32.71% 2.81%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 1.33 M $123.31 M   7.83% 2.66%
NOVO HOLDINGS A/S 05/15/2026 1.33 M $122.40 M   4.82% 2.64%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.26 M $116.42 M   18.54% 2.51%
TANG CAPITAL MANAGEMENT LLC 05/15/2026 1.24 M $114.18 M   0.00% 2.46%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 1.06 M $98.11 M   1,611.63% 2.12%
CITADEL ADVISORS LLC 05/15/2026 1.05 M $97.19 M   25.21% 2.10%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 911.42 K $84.20 M   38.98% 1.82%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2026 811.29 K $74.95 M   6.43% 1.62%
TWO SIGMA INVESTMENTS, LP 05/15/2026 774.84 K $71.58 M   99.42% 1.54%
CAPITAL WORLD INVESTORS 05/13/2026 724.42 K $66.92 M   100.00% 1.44%
BANK OF AMERICA CORP /DE/ 05/18/2026 722.18 K $66.71 M   1.22% 1.44%
FRANKLIN RESOURCES INC 05/13/2026 714.80 K $66.03 M   9.85% 1.42%
CLEARBRIDGE INVESTMENTS, LLC 05/13/2026 671.87 K $62.07 M   -22.41% 1.34%
GOLDMAN SACHS GROUP INC 05/15/2026 662.31 K $61.18 M   -8.56% 1.32%
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2026 625.00 K $57.74 M   100.00% 1.25%
LORD, ABBETT & CO. LLC 05/14/2026 617.06 K $57.00 M   6.39% 1.23%
BANK OF NEW YORK MELLON CORP 05/05/2026 584.52 K $54.00 M   3.35% 1.16%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 582.09 K $53.77 M   32.57% 1.16%
WOODLINE PARTNERS LP 05/15/2026 567.89 K $52.46 M   0.00% 1.13%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 539.03 K $49.80 M   88.56% 1.07%
MORGAN STANLEY 05/15/2026 524.57 K $48.46 M   23.23% 1.05%
FEDERATED HERMES, INC. 05/11/2026 506.21 K $46.76 M   5.03% 1.01%
UBS GROUP AG 05/05/2026 494.99 K $45.73 M   54.31% 0.99%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 479.48 K $44.29 M   -8.09% 0.96%
LOOMIS SAYLES & CO L P 05/14/2026 475.32 K $43.91 M   -7.70% 0.95%
NUVEEN, LLC 04/30/2026 474.23 K $43.81 M   -5.73% 0.94%
CANDRIAM S.C.A. 04/30/2026 464.22 K $42.88 M   -18.50% 0.92%
BAKER BROS. ADVISORS LP 05/15/2026 445.98 K $41.20 M   100.00% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 427.09 K $39.45 M   4.35% 0.85%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 423.51 K $39.12 M   -26.64% 0.84%
BOONE CAPITAL MANAGEMENT LLC 05/15/2026 421.24 K $38.91 M   0.00% 0.84%
MACQUARIE MANAGEMENT HOLDINGS, INC. 05/15/2026 405.32 K $37.44 M   -3.92% 0.81%
FIRST TURN MANAGEMENT, LLC 05/15/2026 400.46 K $36.99 M   -16.84% 0.80%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 400.31 K $36.98 M   -30.21% 0.80%
EMERALD ADVISERS, LLC 05/04/2026 397.26 K $36.70 M   8.21% 0.79%
NORTHERN TRUST CORP 05/14/2026 394.92 K $36.48 M   5.35% 0.79%
NEXT CENTURY GROWTH INVESTORS LLC 05/14/2026 385.54 K $35.62 M   4.76% 0.77%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 05/07/2026 376.47 K $34.78 M   -4.89% 0.75%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 375.00 K $34.64 M   -19.78% 0.75%
MILLENNIUM MANAGEMENT LLC 05/15/2026 368.58 K $34.05 M   50.89% 0.73%

Mirum Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 364 institutional investors and hedge funds held shares of Mirum Pharmaceuticals Inc. The most heavily invested institutionals were:

Frazier Life Sciences Management, L.P.: 7.68 M

JANUS HENDERSON GROUP PLC: 6.95 M

BlackRock, Inc.: 3.85 M

FMR LLC: 1.97 M

STATE STREET CORP: 1.94 M

PRICE T ROWE ASSOCIATES INC /MD/: 1.72 M

135.96% of Mirum Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 73.30 M shares in the last 24 months. This purchase volume represents approximately $6.51 B in transactions.